Beauty is evolving for GLP-1 users.
Reflections. With 12% of Americans on GLP-1s, users are seeking supportive products, from scent to skincare.
Topical takeover. Losing ~7% of facial volume, individuals on weight loss meds report skin laxity alongside dullness, dryness, and hyperpigmentation. Creating a new subcategory, SkinCeuticals, Image Skincare, and Dr. Few Skincare developed specialized serums for “Ozempic face.”
Strand care. Combating associated hair shedding, Nutrafol and Arey tout supplements to fill gaps, while brands like Act+Acre highlight scalp care protocols to prevent loss. A dual prescriber and seller, Hers launched a minoxidil regrowth gummy.
Scent shift. With GLP-1s altering sensory preferences, two camps are emerging — some are seeking fragrance-free products due to nausea, while others gravitate toward foodie-focused gourmands.
Replacing sweet treats, dessert-inspired fragrances are up 24% YoY, with brands like Snif, Eos, and Skylar capitalizing. Beyond eau de parfum, indulgences like Rhode’s birthday lip treatment and Beekman 1802’s bodycare collaboration with Hershey’s are resonating.
Punchline: Weight loss drugs are rewriting beauty routines. As expectations rise, topicals may fall short — pushing consumers toward clinical and medspa solutions.
